Albert Robichaud - Net Worth and Insider Trading

Albert Robichaud Net Worth

The estimated net worth of Albert Robichaud is at least $2 Million dollars as of 2024-05-12. Albert Robichaud is the Chief Scientific Officer of Sage Therapeutics Inc and owns about 136,400 shares of Sage Therapeutics Inc (SAGE) stock worth over $2 Million. Details can be seen in Albert Robichaud's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Albert Robichaud has not made any transactions after 2019-12-09 and currently still holds the listed stock(s).

Transaction Summary of Albert Robichaud

To

Albert Robichaud Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Albert Robichaud owns 1 companies in total, including Sage Therapeutics Inc (SAGE) .

Click here to see the complete history of Albert Robichaud’s form 4 insider trades.

Insider Ownership Summary of Albert Robichaud

Ticker Comapny Transaction Date Type of Owner
SAGE Sage Therapeutics Inc 2019-12-09 Chief Scientific Officer

Albert Robichaud Latest Holdings Summary

Albert Robichaud currently owns a total of 1 stock. Albert Robichaud owns 136,400 shares of Sage Therapeutics Inc (SAGE) as of December 9, 2019, with a value of $2 Million.

Latest Holdings of Albert Robichaud

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SAGE Sage Therapeutics Inc 2019-12-09 136,400 11.90 1,623,160

Holding Weightings of Albert Robichaud


Albert Robichaud Form 4 Trading Tracker

According to the SEC Form 4 filings, Albert Robichaud has made a total of 1 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 25,000 shares on December 9, 2019, which cost Albert Robichaud around $2 Million.

Insider Trading History of Albert Robichaud

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Albert Robichaud Trading Performance

GuruFocus tracks the stock performance after each of Albert Robichaud's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert Robichaud is -28.47%. GuruFocus also compares Albert Robichaud's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert Robichaud within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Albert Robichaud's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Albert Robichaud

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 21.48
Relative Return to S&P 500(%) 17.06

Albert Robichaud Ownership Network

Ownership Network List of Albert Robichaud

No Data

Ownership Network Relation of Albert Robichaud


Albert Robichaud Owned Company Details

What does Sage Therapeutics Inc do?

Who are the key executives at Sage Therapeutics Inc?

Albert Robichaud is the Chief Scientific Officer of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .

Sage Therapeutics Inc (SAGE) Insider Trades Summary

Over the past 18 months, Albert Robichaud made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett , and a net sale of 11,643 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,643 shares of Sage Therapeutics Inc (SAGE) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 8,643 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sage Therapeutics Inc Insider Transactions

No Available Data

Albert Robichaud Mailing Address

Above is the net worth, insider trading, and ownership report for Albert Robichaud. You might contact Albert Robichaud via mailing address: 215 First Street, Cambridge Ma 02142.

Discussions on Albert Robichaud

No discussions yet.